Procedural sedation and analgesia (PSA) refers to the
pharmacologic technique of managing a child’s pain and anxiety in order
to successfully perform a diagnostic or therapeutic procedure safely
[1].
The sequential approach to PSA includes defining the
goal for sedation, performing a pre-sedation health check-up, assigning
a qualified person to administer the sedation, choosing the appropriate
drug and appropriate monitoring devices, defining the protocol for
monitoring during sedation and the discharge criteria. The same should
be followed in all settings.
The goals of PSA [2] are: (i) Maintain patient
safety, (ii) Minimize discomfort, (iii) Maximize amnesia,
(iv) Control behavior and/or movement for the safe completion of
the procedure, and (v) Safe discharge.
Pre-sedation evaluation
The important components of this evaluation are: Age
and weight; Relevant diseases and Physical abnormalities; Medication
history; Allergies; Vital signs; Relevant systemic examination; Focused
evaluation of the airway (tonsillar hypertrophy, abnormal anatomy e.g.,
short neck); Fasting status.
Fasting status: The American Society of
Anesthesiologists (ASA) recommendations for fasting prior to procedural
sedation are commonly followed, which are as follows (3): 2 hours
fasting for clear fluids, 4 hours for breast milk, and 6 hours for solid
foods, formula, or milk other than human milk.
Informed consent: An informed consent should be
obtained from the primary caregiver before sedating the child. The
components of informed consent include details of the procedure being
performed, specific medications that will be administered, and potential
adverse effects.
Personnel
Apart from minimal sedation, all other levels of
sedation ideally require at least two trained healthcare professionals
[4]. One person is responsible for administering sedation and carrying
out the procedure (primary practioner), while the other person’s
(assistant) responsibility is to monitor appropriate physiologic
parameters and to assist in any supportive or resuscitation measures, if
required. The primary practioner should preferably possess advanced
pediatric airway skills and the assistant should be capable of providing
pediatric basic life support.
Choice of Drugs
The choice of drugs (Table I) for
procedural sedation depends various factors like: type of the procedure,
target level of sedation, specific patient profile, skill of the
practioner, and contraindication and side effect profile.
TABLE I Recommended Strategies for Procedural Sedation and Analgesia
Procedure |
|
Sedation /Analgesia options |
Comments |
Non-painful procedures* |
|
|
|
ECG,
ECHO, USG |
• |
Oral
Triclofos |
Sedation not required routinely |
|
• |
Midazolam (IN/PO/IV/IM) |
|
CT,
MRI (non-intervention) |
• |
IV
Midazolam |
Propofol infusion is an option for children requiring |
|
• |
Propofol |
prolonged sedation for MRI; should be used only |
|
|
|
under supervision of a specialist |
Procedures associated
with low level of pain and high anxiety |
Incision and drainage, |
• |
Comforting alone |
|
Laceration repair, Pleural tap |
• |
Midazolam + LA |
|
Lumbar puncture |
• |
EMLA
applied 60 min before |
Avoid Ketamine in increased ICP |
|
|
procedure
+ LA + Midazolam |
|
|
• |
Ketamine |
|
Procedures associated
with high level of pain, high anxiety or both |
BMA,
Chest tube insertion, |
• |
Ketamine (alone or in combination |
Propofol should be used only under supervision of
|
|
|
|
|
Liver/Renal biopsy |
|
with
Midazolam or Propofol) |
a
specialist |
|
• |
Fentanyl + Midazolam |
|
*Do not use ketamine or opioids for
non-painful procedures. IV-intravenous, IM-intramuscular, PO-per
oral, IN-intranasal, PR-per rectal, ECHO-echocardiography, USG-ultrasonography,
LA-local anesthetic, ICP- Intracranial Pressure, BMA- bone
marrow aspiration, EMLA- eutectic mixture of local anesthetics.
|
Sedation for non-painful procedures: Imaging
studies constitute the most common non-painful procedures for which
children undergo sedation. The chosen agent or agents should have a
quick onset of action, should maintain airway reflexes, and have limited
impact on breathing and hemodynamic stability. Analgesia is not
necessary for these procedures. Common options for non-painful
procedures include sedatives such as midazolam and triclofos. One may
also consider using non-pharmacologic approaches.
Sedation for painful procedures: For children
undergoing painful procedures, adequate sedation as well as analgesia is
required. The options for painful procedures include:
1. Ketamine, either alone or in combination with
midazolam or propofol,
2. Opioids (e.g., fentanyl) combined with
midazolam,
3. Opioids combined with propofol,
4. Nitrous oxide alone
Table II provides dosing of the commonly used
medications.
TABLE II Commonly used Pharmacological Agents for Pediatric Procedural Sedation and Analgesia [5]
Drug |
Dose |
Onset/Duration |
Side effects
|
Midazolam (S) |
IV (0.5-5 yr): 0.0-0.1mg/kg, |
Onset: 2-3 min |
Respiratory depression, hypotension
|
|
(May repeat every 2-5min, maximum
|
Duration: 45-60 min |
Reversal: Flumazenil |
|
total dose 6 mg) |
|
|
|
IV (6-12 yr): 0.025-0.05 mg/kg,
|
|
|
|
(maximum total dose 10 mg) |
|
|
|
IN: 0.2-0.5 mg/kg |
|
|
Triclofos (S) |
PO: 20 mg/kg/dose |
– |
Monitor child during and after procedure |
Fentanyl (A) |
IV: 1.0 µg/kg/dose, |
Onset: 2-3 min |
Respiratory depression, chest wall
|
|
(May repeat every 3 min,
|
Duration: 30-60 min |
rigidity (after rapid iv push). |
|
maximum dose 4-5µg/kg) |
|
Reversal: Naloxone |
Ketamine (S/A) |
IV: 1-1.5 mg/kg,
|
Onset: 1-2 min |
Vomiting, increased salivation,
|
|
(May repeat ˝ dose every 10 min) |
Duration: 15-30 min |
laryngospasm, emergence reaction. |
|
IM: 4-5 mg/kg, may repeat after 10 min |
|
C/I: Age <3 mo, increased ICP, glaucoma |
S-sedative, A-analgesic, IV-intravenous, IM-intramuscular,
PO-per oral, IN-intranasal, C/I-contraindications,
ICP-Intracranial Pressure |
Monitoring and Documentation
Before proceeding with sedation, the practitioner
should check the necessary equipment (suction apparatus, oxygen supply,
and size appropriate airway equipment), monitors (pulse oximeter and
other monitors as appropriate for the procedure like ECG, noninvasive
BP) and drugs (the basic life support drugs).
All children undergoing any degree of sedation should
be monitored carefully. At a minimum, the vital signs should be measured
at baseline, after administration of the drug, on completion of the
procedure, during early recovery, and at the completion of recovery. If
an increased depth of sedation is anticipated or the child has an
underlying illness, the frequency of measurement of vital signs should
be increased (e.g., to every five minutes with deep sedation)
[5]. The importance of proper documentation cannot be over-emphasized.
The patient’s chart should include the name, route, site, time, dosage,
and a time based record of patient’s vitals until the criteria for safe
discharge are attained.
Discharge criteria: After procedural sedation,
children should be discharged only after they have awakened to their
baseline mental and ambulatory status. Discharge instructions should be
clearly explained to the caregivers with special emphasis on watching
carefully for signs of respiratory distress.
1. Doyle L, Colletti JE. Pediatric procedural
sedation and analgesia. Pediatr Clin N Am. 2006;53:279-92.
2. American Academy of Pediatrics, American Academy
of Pediatric Dentistry, Coté CJ, Wilson S. Guidelines for monitoring and
management of pediatric patients during and after sedation for
diagnostic and therapeutic procedures: an update. Pediatrics.
2006;118:2587-2602.
3. American Society of Anesthesiologists. Practice
guidelines for preoperative fasting and the use of pharmacologic agents
to reduce the risk of pulmonary aspiration: applications to healthy
patients undergoing elective procedures. Anesthesiol. 1999;90:896-905.
4. NICE Clinical Guideline 112. Sedation in children
and young people. 2010. Available at:
http://www.nice.org.uk/nicemedia/live/13296/52124/52124.pdf. Accessed on
21 January, 2013.
5. Krauss B, Green SM. Sedation and analgesia for procedures in
children. N Engl J Med. 2000;342:938-45.